Effectiveness and safety of Tolvaptan in infants with congenital heart disease.
Haruhide SakaguchiDaishi HiranoAya SaitoYoichi TakemasaChisato UmedaSaori MiwaAkira ItoKimihiko OishiPublished in: Pediatrics international : official journal of the Japan Pediatric Society (2023)
Tolvaptan can be used safely and efficiently in infants with CHD. From the perspective of adverse effects, initiating administration at a lower dosage is preferable because this was found to be sufficiently effective.